PEG & ADCs
- Development of Current Four Generation ADCs And Next Generation ADCs
- Summary of Approved HER2 ADCs on The Market & in Clinical Trials
- Nectin-4: New Antibody-Drug Conjugate (ADC) Target
- Novel FRα-targeting Antibody-drug Conjugates (ADCs)
- ADC Drugs: Some Challenges To Be Solved
- Antibody–Drug Conjugate Payloads: MMAE & MMAF
- Beyond HER3-DXd: New Frontiers in HER3-Targeted Therapies for Lung Cancer
- Dual-Payload ADCs: A Revolutionary Leap in Targeted Cancer Therapy
